CAS 1018899-04-1
:Sotagliflozin
Description:
Sotagliflozin is a medication primarily used in the management of type 1 and type 2 diabetes mellitus. It functions as a dual inhibitor of sodium-glucose co-transporter 1 (SGLT1) and sodium-glucose co-transporter 2 (SGLT2), which are proteins involved in glucose reabsorption in the kidneys and intestines. By inhibiting these transporters, sotagliflozin promotes the excretion of glucose through urine and reduces glucose absorption in the gastrointestinal tract, thereby helping to lower blood sugar levels. The compound is characterized by its chemical structure, which includes specific functional groups that contribute to its pharmacological activity. Sotagliflozin is typically administered orally and may be used in conjunction with other antidiabetic medications. Its safety profile includes potential side effects such as urinary tract infections and dehydration, which are common with SGLT2 inhibitors. Overall, sotagliflozin represents a novel approach to diabetes management, targeting multiple pathways to improve glycemic control.
Formula:C21H25ClO5S
InChI:InChI=1S/C21H25ClO5S/c1-3-26-15-7-4-12(5-8-15)10-14-11-13(6-9-16(14)22)20-18(24)17(23)19(25)21(27-20)28-2/h4-9,11,17-21,23-25H,3,10H2,1-2H3/t17-,18-,19+,20+,21-/m1/s1
InChI key:InChIKey=QKDRXGFQVGOQKS-CRSSMBPESA-N
SMILES:O[C@H]1[C@@H](O[C@H](SC)[C@@H](O)[C@@H]1O)C2=CC(CC3=CC=C(OCC)C=C3)=C(Cl)C=C2
Synonyms:- (5S)-Methyl 5-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-1-thio-β-<span class="text-smallcaps">L</span>-xylopyranoside
- Lp 802034
- Lx-4211
- Sotagliflozin
- Zynquista
- β-<span class="text-smallcaps">L</span>-Xylopyranoside, methyl 5-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-1-thio-, (5S)-
- β-L-Xylopyranoside, methyl 5-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-1-thio-, (5S)-
- (5S)-Methyl 5-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-1-thio-β-L-xylopyranoside
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 8 products.
β-L-Xylopyranoside, methyl 5-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-1-thio-, (5S)-
CAS:Formula:C21H25ClO5SPurity:98%Color and Shape:SolidMolecular weight:424.9382(2S,3R,4R,5S,6R)-2-[4-Chloro-3-[(4-Ethoxyphenyl)Methyl]Phenyl]-6-Methylsulfanyloxane-3,4,5-Triol
CAS:<p>(2S,3R,4R,5S,6R)-2-[4-Chloro-3-[(4-Ethoxyphenyl)Methyl]Phenyl]-6-Methylsulfanyloxane-3,4,5-Triol</p>Purity:98%Molecular weight:424.94g/molSotagliflozin
CAS:<p>Sotagliflozin (LP-802034) is an orally bioavailable inhibitor of the sodium-glucose co-transporter subtype 1 (SGLT1) and 2 (SGLT2), with potential</p>Formula:C21H25ClO5SPurity:99% - 99.86%Color and Shape:SolidMolecular weight:424.94LX4211
CAS:<p>Inhibitor of sodium-glucose cotransporters SGLT1 and SGLT2</p>Formula:C21H25ClO5SPurity:Min. 95%Color and Shape:PowderMolecular weight:424.94 g/mol
![β-L-Xylopyranoside, methyl 5-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-1-thio-, (5S)-](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb%2FDA0005U7.jpg&w=3840&q=75)
![(2S,3R,4R,5S,6R)-2-[4-Chloro-3-[(4-Ethoxyphenyl)Methyl]Phenyl]-6-Methylsulfanyloxane-3,4,5-Triol](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F54%2Fthumb%2FOR1029396.jpg&w=3840&q=75)
